The implication of ‘unknown significance’ variants in next‐generation sequencing in diagnosis and donor selection for allogenic haematopoietic stem cell transplantation. Report of a case of myelodysplastic syndrome with a polymorphism in the tyrosine kinase 2 ( TYK2 ) gene
Open Access
- 8 April 2020
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 189 (4), E180-E182
- https://doi.org/10.1111/bjh.16590
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- The Value of Next-Generation Sequencing in the Screening and Evaluation of Hematologic Neoplasms in Clinical PracticeAmerican Journal of Clinical Pathology, 2019
- Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemiaBritish Journal of Haematology, 2019
- The evolving role of next generation sequencing in myelodysplastic syndromesBritish Journal of Haematology, 2019
- Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AMLBlood, 2018
- Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopeniaScientific Reports, 2018
- Tyrosine kinase 2 – Surveillant of tumours and bona fide oncogeneCytokine, 2017
- NGS-Based Assay for the Identification of Individuals Carrying Recessive Genetic Mutations in Reproductive MedicineHuman Mutation, 2016